Auto logout in seconds.
Continue LogoutRheumatoid arthritis is a chronic autoimmune disease that affects over 1.3 million Americans. If patients do not receive an appropriate diagnosis and treatment plan, it can lead to irreversible joint damage. While there is no cure, there are now many treatment options for patients to relieve and control their symptoms.
Two care gaps that patients commonly experience are delays in diagnosis and challenges with accessing medication. Advisory Board undertook both qualitative and quantitative research to better quantify these gaps, understand why they occur, and identify potential solutions for all stakeholders. Below, you'll find our research briefings discussing these care gaps.
Research Briefing: Delays in diagnosis for rheumatoid arthritis patients
Research Briefing: Challenges rheumatoid arthritis patients face in accessing medication
Create your free account to access 1 resource, including the latest research and webinars.
You have 1 free members-only resource remaining this month.
1 free members-only resources remaining
1 free members-only resources remaining
You've reached your limit of free insights
Never miss out on the latest innovative health care content tailored to you.
You've reached your limit of free insights
Never miss out on the latest innovative health care content tailored to you.
This content is available through your Curated Research partnership with Advisory Board. Click on ‘view this resource’ to read the full piece
Email ask@advisory.com to learn more
Never miss out on the latest innovative health care content tailored to you.
This is for members only. Learn more.
Never miss out on the latest innovative health care content tailored to you.